News

Delivering for Patients and Sites in 2025

Implementing sensor-based digital health technologies in clinical trials: Key considerations from the eCOA Consortium

How eCOA/ePRO is Transforming Clinical Trials

Easing the Patient Journey: New Technologies, Improving Diversity and Rigorous Standards

Understanding Acceptability of eConsent from a Global, Ethical, and Industry Perspective

uMotif Showcases Modern eCOA/ePRO and eConsent to Ease Patient and Site Journey in Clinical Trials, Real-World Studies at Fall 2024 Life Sciences Conferences

uMotif Names Florence Mowlem, PhD Chief Scientific Officer

uMotif Buys ClinOne; Integrates Site Applications into Most Modern eCOA/ePRO Platform

Outsourcing Pharma Interview with Elaine Maynard